Myriad Supreme Court Case Has Promising Outcome for Immunomic Therapeutics

Immunomic Therapies, based in Rockville, Md., is satisfied with the Supreme Court’s decision to overturn Myriad’s patents on the BRCA genes. The company claims that none of its patented membrane proteins will be affected and that the ruling will give the company greater access to data.
BusinessWire